Trial Profile
An Open-Label Study to Evaluate the Effect of the Administration of FX006 on Synovial Inflammation in Patients With Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Jan 2024
Price :
$35
*
At a glance
- Drugs Triamcinolone (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Flexion Therapeutics
- 26 May 2020 Status changed from active, no longer recruiting to completed.
- 12 Mar 2020 Results published in the Flexion Therapeutics media release
- 08 Oct 2019 Status changed from recruiting to active, no longer recruiting.